Skip to content
Study details
Enrolling now

Treating Polysubstance Use Using a Novel Digital Technology

Friends Research Institute, Inc.
NCT IDNCT05766631ClinicalTrials.gov data as of Apr 2026
Phase

Phase 3

Target enrollment

240

Study length

about 4.2 years

Ages

18+

Locations

5 sites in MD

What this study is about

This trial is testing if using an app to reduce opioid and cocaine use, in addition to methadone treatment, helps people stay in treatment longer, use less of these drugs, and improve their quality of life. Participants will be randomly assigned to either use the app or receive standard methadone treatment.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in DynamiCare Health
  • 2.Take Methadone Treatment-As-Usual

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Changes in Quality of Life through 48 Weeks

Body systems

Psychiatry / Mental Health